工程介质干细胞衍生外细胞囊泡用于治疗慢性脏疾病
Hsiu-Jung Liao1,2, Kai-Hsiang Shu3, Wei-Che Yu4
1Department of Medical Research, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Tissue engineering and regenerative medicine
|December 3, 2025
概括
介酶干细胞衍生的外体细胞 (MSC-Exos) 显示出治疗慢性病 (CKD) 的前景. 将这些外体封装在水凝中可以增强它们的稳定性和受控释放,从而改善脏修复的治疗结果.
科学领域:
- 再生医学是一种再生医学.
- 生物材料科学 生物材料科学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 慢性病 (CKD) 是一种进展性疾病,死亡率高.
- 目前对CKD的治疗方法有限,需要新的治疗策略.
研究的目的:
- 审查介质干细胞衍生异构体 (MSC-Exos) 在CKD中的作用.
- 探索水凝生物材料在CKD中增强MSC-Exo疗法的潜力.
主要方法:
- 审查关于MSC-Exos及其治疗潜力的当前文献.
- 对控制分娩的外体体-水凝复合系统的研究.
主要成果:
- MSC-Exos具有固有的再生和免疫调节特性.
- 外体作为自然载体,有针对性地传递治疗载荷.
- 水凝封装改善了MSC-Exo的稳定性和脏组织中持续释放.
结论:
- MSC-Exos在CKD中显示出显著的保护作用.
- 基于水凝的输送系统为提高MSC-Exo疗法的疗效提供了一个有希望的平台.
- 这种方法代表了在CKD治疗中精准医学的创新策略.
相关概念视频
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
164
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
164


